122 related articles for article (PubMed ID: 10767598)
1. Evaluation of absorption enhancement for a potent cyclopeptidic alpha(nu)beta(3)-antagonist in a human intestinal cell line (Caco-2).
Kamm W; Jonczyk A; Jung T; Luckenbach G; Raddatz P; Kissel T
Eur J Pharm Sci; 2000 May; 10(3):205-14. PubMed ID: 10767598
[TBL] [Abstract][Full Text] [Related]
2. Effects of permeation enhancers on the transport of a peptidomimetic thrombin inhibitor (CRC 220) in a human intestinal cell line (Caco-2).
Werner U; Kissel T; Reers M
Pharm Res; 1996 Aug; 13(8):1219-27. PubMed ID: 8865316
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
[TBL] [Abstract][Full Text] [Related]
4. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells.
Lindmark T; Kimura Y; Artursson P
J Pharmacol Exp Ther; 1998 Jan; 284(1):362-9. PubMed ID: 9435199
[TBL] [Abstract][Full Text] [Related]
5. Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption.
Ribadeneira MD; Aungst BJ; Eyermann CJ; Huang SM
Pharm Res; 1996 Feb; 13(2):227-33. PubMed ID: 8932441
[TBL] [Abstract][Full Text] [Related]
6. The effect of conjugated linoleic acid and medium-chain fatty acids on transepithelial calcium transport in human intestinal-like Caco-2 cells.
Jewell C; Cashman KD
Br J Nutr; 2003 May; 89(5):639-47. PubMed ID: 12720584
[TBL] [Abstract][Full Text] [Related]
7. Prodrug approach for alphaIIbbeta3-peptidomimetic antagonists to enhance their transport in monolayers of a human intestinal cell line (Caco-2): comparison of in vitro and in vivo data.
Kamm W; Raddatz P; Gante J; Kissel T
Pharm Res; 1999 Oct; 16(10):1527-33. PubMed ID: 10554093
[TBL] [Abstract][Full Text] [Related]
8. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.
Maher S; Devocelle M; Ryan S; McClean S; Brayden DJ
Int J Pharm; 2010 Mar; 387(1-2):154-60. PubMed ID: 20025949
[TBL] [Abstract][Full Text] [Related]
9. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
Ingels F; Beck B; Oth M; Augustijns P
Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
[TBL] [Abstract][Full Text] [Related]
10. Absorption properties of micellar lipid metabolites into Caco2 cells.
Tsuzuki W
Lipids; 2007 Jul; 42(7):613-9. PubMed ID: 17582542
[TBL] [Abstract][Full Text] [Related]
11. Development of simulated intestinal fluids containing nutrients as transport media in the Caco-2 cell culture model: assessment of cell viability, monolayer integrity and transport of a poorly aqueous soluble drug and a substrate of efflux mechanisms.
Lind ML; Jacobsen J; Holm R; Müllertz A
Eur J Pharm Sci; 2007 Dec; 32(4-5):261-70. PubMed ID: 17890067
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of sodium taurocholate to the absorption of cefquinome.
Yu Q; Cao Y; Liu LF; Jiang SX; Yang Q
Pak J Pharm Sci; 2016 Jan; 29(1):139-43. PubMed ID: 26826827
[TBL] [Abstract][Full Text] [Related]
13. Transepithelial electrical resistance is not a reliable measurement of the Caco-2 monolayer integrity in Transwell.
Mukherjee T; Squillantea E; Gillespieb M; Shao J
Drug Deliv; 2004; 11(1):11-8. PubMed ID: 15168786
[TBL] [Abstract][Full Text] [Related]
14. A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells.
Brayden DJ; Gleeson J; Walsh EG
Eur J Pharm Biopharm; 2014 Nov; 88(3):830-39. PubMed ID: 25460147
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of paracellular transport of heparin disaccharide across Caco-2 cell monolayers.
Cho SY; Kim JS; Li H; Shim C; Linhardt RJ; Kim YS
Arch Pharm Res; 2002 Feb; 25(1):86-92. PubMed ID: 11885699
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the potential of ion pair formation to improve the oral absorption of two potent antiviral compounds, AMD3100 and PMPA.
Van Gelder J; Witvrouw M; Pannecouque C; Henson G; Bridger G; Naesens L; De Clercq E; Annaert P; Shafiee M; Van den Mooter G; Kinget R; Augustijns P
Int J Pharm; 1999 Sep; 186(2):127-36. PubMed ID: 10486430
[TBL] [Abstract][Full Text] [Related]
17. Bio-relevant media to assess drug permeability: sodium taurocholate and lecithin combination or crude bile?
Berginc K; Trontelj J; Kristl A
Int J Pharm; 2012 Jun; 429(1-2):22-30. PubMed ID: 22449411
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of absorption enhancers in Caco-2 cell monolayers.
Sakai M; Imai T; Ohtake H; Otagiri M
J Pharm Pharmacol; 1998 Oct; 50(10):1101-8. PubMed ID: 9821655
[TBL] [Abstract][Full Text] [Related]
20. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.
Brayden DJ; Walsh E
AAPS J; 2014 Sep; 16(5):1064-76. PubMed ID: 24961919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
